Literature DB >> 2380918

Estimating the rate of thiopental blood-brain equilibration using pseudo steady state serum concentrations.

P O Maitre1, M Bührer, S L Shafer, D R Stanski.   

Abstract

The equilibration between drug serum concentration and drug effect under non-steady state concentrations has been classically modeled using an effect compartment where the transfer from the serum to the effect compartment is considered to be a first-order process. The purpose of the present study was to examine whether an effect compartment with first-order transfer was adequate for describing thiopental serum concentration-EEG pharmacodynamics. The study has two facets: (i) Successive pseudo steady state serum concentrations of thiopental having a square wave shape were produced and maintained in six human subjects by means of a computer-driven infusion pump. An aperiodic wave form transformation of the electroencephalogram (EEG) was used as a continuous measure of thiopental EEG drug effect. The time course of the EEG effect following each thiopental serum concentration square wave showed an exponential pattern. The first-order rate constant for equilibration of the effect site concentration with the drug serum concentration (keo) was estimated by fitting a monoexponential model to the effect vs. time data resulting from the pseudo steady state thiopental serum concentration profile. (ii) In a second experiment, data were obtained from a classical design, i.e., a zero-order intravenous infusion of thiopental. The same subjects were studied. The keo was estimated by means of a semiparametric iterative method using convolution (effect compartment, transfer of drug from serum to site of action is assumed to be a first-order process). The mean pseudo steady state value for keo of 0.51 min-1 was not different from the mean value of 0.46 min-1 from the semi parametric approach when data from a linear portion of the drug concentration vs. effect curve were examined. The pseudo steady state technique gave inaccurate estimates of keo in the nonlinear portion of the thiopental concentration vs. response curve, i.e., at the peak of the biphasic concentration-effect relationship.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2380918     DOI: 10.1007/bf01062198

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  14 in total

1.  Cerebral circulation and metabolism during thiopental anesthesia and hyper-ventilation in man.

Authors:  E C PIERCE; C J LAMBERTSEN; S DEUTSCH; P E CHASE; H W LINDE; R D DRIPPS; H L PRICE
Journal:  J Clin Invest       Date:  1962-08       Impact factor: 14.808

2.  Relationship between the pharmacokinetics and pharmacodynamics of procainamide.

Authors:  R L Galeazzi; L Z Benet; L B Sheiner
Journal:  Clin Pharmacol Ther       Date:  1976-09       Impact factor: 6.875

3.  An electroencephalographic processing algorithm specifically intended for analysis of cerebral electrical activity.

Authors:  T K Gregory; D C Pettus
Journal:  J Clin Monit       Date:  1986-07

4.  Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models.

Authors:  J D Unadkat; F Bartha; L B Sheiner
Journal:  Clin Pharmacol Ther       Date:  1986-07       Impact factor: 6.875

5.  Pharmacokinetics and dynamics of muscle relaxants.

Authors:  D R Stanski; L B Sheiner
Journal:  Anesthesiology       Date:  1979-08       Impact factor: 7.892

6.  Kinetics of interaction between drugs and biological systems.

Authors:  G Segre
Journal:  Farmaco Sci       Date:  1968-10

7.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: an improved algorithm.

Authors:  D Verotta; L B Sheiner
Journal:  Comput Appl Biosci       Date:  1987-11

8.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

Authors:  L B Sheiner; D R Stanski; S Vozeh; R D Miller; J Ham
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

9.  Pharmacokinetics and anesthetic potency of a thiopental isomer.

Authors:  D R Stanski; P G Burch; S Harapat; R K Richards
Journal:  J Pharm Sci       Date:  1983-08       Impact factor: 3.534

10.  An evaluation of the accuracy of pharmacokinetic data for the computer assisted infusion of alfentanil.

Authors:  M E Ausems; D R Stanski; C C Hug
Journal:  Br J Anaesth       Date:  1985-12       Impact factor: 9.166

View more
  5 in total

Review 1.  [Effect compartment equilibration and time-to-peak effect. Importance of a pharmacokinetic-pharmacodynamic principle for the daily clinical practice].

Authors:  J Bruhn; P M Schumacher; T W Bouillon
Journal:  Anaesthesist       Date:  2005-10       Impact factor: 1.041

2.  Estimation of amobarbital plasma-effect site equilibration kinetics. Relevance of polyexponential conductance functions.

Authors:  J W Mandema; P Veng-Pedersen; M Danhof
Journal:  J Pharmacokinet Biopharm       Date:  1991-12

3.  The impact of arteriovenous concentration differences on pharmacodynamic parameter estimates.

Authors:  B Tuk; M Danhof; J W Mandema
Journal:  J Pharmacokinet Biopharm       Date:  1997-02

4.  Plasma concentration clamping in the rat using a computer-controlled infusion pump.

Authors:  L L Gustafsson; W F Ebling; E Osaki; S Harapat; D R Stanski; S L Shafer
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

5.  Quantification of neocortical slice diffusion characteristics using pharmacokinetic and pharmacodynamic modelling.

Authors:  Logan J Voss; Claudia van Kan; James W Sleigh
Journal:  ISRN Neurosci       Date:  2013-09-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.